Catalogo dei prodotti della ricerca

FRONTONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.003
EU - Europa 704
AS - Asia 669
SA - Sud America 111
AF - Africa 19
OC - Oceania 5
Totale 3.511
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.978
SG - Singapore 284
IT - Italia 215
HK - Hong Kong 130
IN - India 117
UA - Ucraina 103
BR - Brasile 91
DE - Germania 88
SE - Svezia 88
CN - Cina 77
FI - Finlandia 64
RU - Federazione Russa 50
GB - Regno Unito 25
AT - Austria 24
CA - Canada 18
AR - Argentina 13
IQ - Iraq 10
BD - Bangladesh 9
IE - Irlanda 9
TR - Turchia 9
BG - Bulgaria 8
NL - Olanda 6
BE - Belgio 5
ID - Indonesia 5
JP - Giappone 5
ZA - Sudafrica 5
RO - Romania 4
TG - Togo 4
VE - Venezuela 4
AU - Australia 3
JO - Giordania 3
NP - Nepal 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
CH - Svizzera 2
ET - Etiopia 2
FR - Francia 2
IR - Iran 2
KR - Corea 2
LT - Lituania 2
MX - Messico 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
UZ - Uzbekistan 2
VN - Vietnam 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
GR - Grecia 1
JE - Jersey 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
MZ - Mozambico 1
PL - Polonia 1
QA - Qatar 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 3.511
Salva come PNG Salva come JPEG
Città #
Fairfield 327
Woodbridge 166
Ashburn 160
Singapore 157
Chandler 155
Hong Kong 129
Houston 128
Seattle 106
Cambridge 89
Wilmington 83
Ann Arbor 82
Rome 73
Princeton 53
Plano 46
Jacksonville 42
Beijing 35
Dearborn 35
Boston 33
San Paolo di Civitate 31
Lawrence 27
Santa Clara 25
Des Moines 24
Grafing 20
Munich 20
Vienna 18
Millbury 17
Los Angeles 16
Helsinki 15
San Diego 15
Frankfurt am Main 14
New York 12
Andover 11
Cosenza 11
Moscow 10
Norwalk 10
Columbus 9
Federal 9
Toronto 9
Yubileyny 9
Dublin 8
Sofia 8
Boardman 7
Falkenstein 7
Falls Church 7
Milan 6
Turku 6
Brussels 5
Dallas 5
Fasano 5
Hefei 5
Jakarta 5
Mannheim 5
Nuremberg 5
Baghdad 4
Fremont 4
Lomé 4
London 4
Nanjing 4
São Paulo 4
Venezia 4
Amman 3
Amsterdam 3
Brasília 3
Chapel Hill 3
Dhaka 3
Genzano 3
Lidköping 3
Ottawa 3
Recife 3
Tokyo 3
Addis Ababa 2
Bari 2
Belo Horizonte 2
Bern 2
Bühl 2
Castelnuovo del Garda 2
Conegliano 2
Curitiba 2
Durban 2
Foggia 2
Hanoi 2
Hyderabad 2
Istanbul 2
Jaboatão dos Guararapes 2
Johannesburg 2
Lappeenranta 2
Laurel 2
Manchester 2
Modugno 2
Montes Claros 2
Naples 2
Napoli 2
New Delhi 2
Padova 2
Philadelphia 2
Phoenix 2
Porto Recanati 2
Porto Velho 2
Portsmouth 2
Riyadh 2
Totale 2.433
Salva come PNG Salva come JPEG
Nome #
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis 145
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS 122
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 120
Ballismo, atetosi e discinesie parossistiche 118
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study 105
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 104
Photophobia in multiple sclerosis 97
Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: a case-control study. 92
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis 91
MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis. 87
Parkinson's disease related pain: a review of recent findings. 87
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 87
Can the Expanded Disability Status Scale be assessed by telephone? 86
Cost minimization analysis of BoNT-As in the treatment of upper limb spasticity and cervical dystonia 86
Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis. 84
Cardiac autonomic dysfunction in relapsing-remitting multiple sclerosis during a stable phase 82
Early diagnosis of secondary progressive multiple sclerosis: focus on fluid and neurophysiological biomarkers 81
Early fibrinolysis and brain protection: design of a four-arm clinical trial in brain infarction. 80
Fatigue in Parkinson's disease: Motor or non-motor symptom? 79
Reversed laterality of cerebral functions in a non-right-hander: neuropsychological and spect findings in a case of 'atypical' dominance. 78
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 78
Effect of stress on cardiovascular regulation in neurological diseases with dysautonomia. 75
Thrombolysis in acute ischemic stroke 74
AUTONOMIC DYSFUNCTION IN MULTIPLE SCLEROSIS 73
MAGNETIC RESONANCE IMAGING OUTCOME OF NEW ENHANCING LESIONS IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS TREATED WITH INTERFERON-B1A 68
MRI in multiple sclerosis during the menstrual cycle: Relationship with sex hormone patterns 68
Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis. 67
Invasive treatment of acute stroke. 67
INVASIVE TREATMENT OF ACUTE STROKE 66
Cardiac autonomic dysfunction in patients with alzheimer's disease: possible pathogenetic mechanisms. 65
Determinants of Gd-enhanced MRI response to IFN-beta-I a treatment in relapsing-remitting multiple sclerosis 64
Autonomic dysfunction in MS 64
Update on calcium antagonists in cerebrovascular diseases. 62
Pharmacological approach to acute ischemic stroke 60
Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study 60
Treatment of Acute Ischemic Stroke 59
Does hyperglicemia play a role on the outcome of acute ischemic stroke patients? 57
No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing-remitting multiple sclerosis. 56
Malattie cerebrovascolari. 55
POWER SPECTRUM ANALYSIS CONTRIBUTION TO THE DETECTION OF CARDIOVASCULAR DYSAUTONOMIA IN MULTIPLE SCLEROSIS 54
Malattie cerebrovascolari 54
NO INCREASE OF SERUM ANTIBODIES DURING THERAPY WITH RECOMBINANT HUMAN INTERFERON-B1A IN RELAPSING-REMITTING MULTIPLE SCLEROSIS 48
Chronic Cerebro-Spinal Venous Insufficiency is not significantly associated to Relapsing-Remitting Multiple Sclerosis. 48
Correlations between sexual hormones and disease activity on MRI in multiple sclerosis 47
Controlled clinical trials in stroke. 47
Magnetic resonance disease activity in multiple sclerosis (MS): correlation with menstrual cycle phase and hormonal parameters 41
Malignant gastric carcinoid and paraneoplastic cerebellar degeneration 30
What are we learning form clinical trials in acute cerebral ischemia? 28
Evaluation of medical treatment in acute ischemic stroke 26
Magnetic resonance imaging outcome of new enhancing lesions in relapsing-remitting multiple sclerosis patients treated with interferon beta1a. 26
Totale 3.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021251 29 23 10 18 4 24 3 23 21 69 20 7
2021/2022506 3 20 36 25 72 14 18 44 43 33 86 112
2022/2023539 98 106 42 40 58 68 5 34 56 5 16 11
2023/2024224 11 40 3 18 15 25 1 29 0 26 32 24
2024/2025784 19 29 20 31 27 39 46 50 106 77 60 280
2025/202673 73 0 0 0 0 0 0 0 0 0 0 0
Totale 3.598